Literature DB >> 21603350

Long-term Alendronate Therapy and Subtrochanteric Femoral Fractures.

Satish Pasala, Alan Burshell, Field Ogden.   

Abstract

Entities:  

Keywords:  Alendronate; subtrochanteric femoral fracture; suppressed bone turnover

Year:  2010        PMID: 21603350      PMCID: PMC3096181     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


× No keyword cloud information.
  2 in total

1.  Severely suppressed bone turnover: a potential complication of alendronate therapy.

Authors:  Clarita V Odvina; Joseph E Zerwekh; D Sudhaker Rao; Naim Maalouf; Frank A Gottschalk; Charles Y C Pak
Journal:  J Clin Endocrinol Metab       Date:  2004-12-14       Impact factor: 5.958

2.  Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.

Authors:  Jennifer P Schneider
Journal:  Geriatrics       Date:  2009-01
  2 in total
  1 in total

1.  Bisphosphonates-induced Atypical Subtrochanteric Fracture Femur: A Case Report.

Authors:  Siddhart Yadav; Vikram Khanna
Journal:  Cureus       Date:  2018-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.